4Avvisati G,Lococo F,Mandelli F.Acute promyelocytic leukemia:clinical and morphologic features and prognostic factors[J].Semin Hematol,2001,38(1):4-12.
2Procu P, Danielson C F, Orai A, et al. Therapentic lenkapheresis in hyperleukoeytie lenkemia: lack of correlation between degree of eytoreduetion and early mortality rate. Br J Hematol, 1997, 98:433-436.
3Shanghai Leukemia Cooperation Group Wang Xiaoqin, Lin Guowei, Wang Jun, et al. Shanghai Huashan Hospital, Shanghai 200040.高白细胞性急性白血病 244 例临床分析[J].中华内科杂志,1997,36(8):532-535. 被引量：27
6Cando S,Kameue T,Massuda N,et al.Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.Thromb Res,2005,116(2):91-100.
7Lopes-Bezerrra LM,Filler SG.Endothelial cell,tissue factor and infectious disease.Braz J Med Biol Res,2003,36(8):987 -991.
8Maugeri N,Brambilla M,Camera M,et al.Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation.J Thromb Haemost,2006,4(6):1323-1330.
9Sabharwal AK,Bajaj SP,Ameri A,et al.Tissue factor pathway inhibitor and won Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis.Am J Respir Crit Care Med,1995,151 (3Pt1):758 -767.
10Tang H,Ivanciu L,Popescu N,et al.Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.Am J Pathol,2007,171 (3):1066-1077.
